Document is current

Article History

Received: 8 May 2023

Accepted: 14 October 2023

First Online: 24 October 2023

Declarations

:

: Our department’s ethical review committee stated their written agreemend to publish this anonymized case report. The patient has decased before consent could be obtained, however we asked the patient’s next of kin for consent, his written agreement is archived at our clinic.

: Informed consent for publication was obtained from the next of kin in the study.

: Mr. Kauffmann-Guerrero recieved consulting fees by Boehringer Ingelheim, BMS, Takeda, Roche, AGMEN, AstraZeneca, GSK and Pfizer. He was also payed for lectures by Boehringer Ingelheim, BMS, Takeda, Roche, AGMEN, AstraZeneca, GSK, Pfizer. There was support for attending meetings or travel by Takeda and Boehringer Ingelheim. Mrs. Tufman recieved funding by Astra Zeneca and is a member of the thoracic oncology group in AIO. Mrs. Kahnert recieved consulting fees by Astra Zeneca. She was also payed for lectures by Boehringer Ingelheim, GSK, AstraZeneca and participated an advisory board oft the latter. ICMJE Disclosure forms were obtained from all authors and can be shown, if requested. The other Authors declare that there is no conflict of interest.

: This case report was written regarding CARE guidelines.